Wesbanco Bank Increased Bristol (BMY) Position; 0 Bullish Analysts Covering Avinger (AVGR)

July 17, 2017 - By Marie Mckinney

Wesbanco Bank Inc increased Bristol (BMY) stake by 8.71% reported in 2016Q4 SEC filing. Wesbanco Bank Inc acquired 36,277 shares as Bristol (BMY)’s stock declined 1.04%. The Wesbanco Bank Inc holds 452,677 shares with $26.46M value, up from 416,400 last quarter. Bristol now has $91.65 billion valuation. The stock rose 0.20% or $0.11 reaching $55.26 per share. About 600 shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since July 17, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Among 3 analysts covering Avinger (NASDAQ:AVGR), 0 have Buy rating, 0 Sell and 3 Hold. Therefore 0 are positive. Avinger had 3 analyst reports since December 29, 2015 according to SRatingsIntel. The firm has “Perform” rating given on Wednesday, April 12 by Oppenheimer. On Tuesday, December 29 the stock rating was downgraded by Dougherty & Company to “Neutral”. Canaccord Genuity downgraded Avinger Inc (NASDAQ:AVGR) on Tuesday, April 11 to “Hold” rating. See Avinger Inc (NASDAQ:AVGR) latest ratings:

12/04/2017 Broker: Oppenheimer Old Rating: Outperform New Rating: Perform Downgrade
11/04/2017 Broker: Canaccord Genuity Old Rating: Buy New Rating: Hold Old Target: $4.30 New Target: $1.00 Downgrade

It closed at $0.453 lastly. It is down 96.51% since July 17, 2016 and is downtrending. It has underperformed by 113.21% the S&P500.

Avinger, Inc. is a commercial-stage medical device company. The company has market cap of $10.66 million. The Firm designs, makes and sells image-guided, catheter systems that are used by physicians to treat patients with peripheral arterial disease . It currently has negative earnings. The Firm focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 4 Sell and 8 Hold. Therefore 37% are positive. Bristol-Myers Squibb Company had 40 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Underweight” rating on Monday, August 24 by Piper Jaffray. As per Monday, December 19, the company rating was upgraded by Jefferies. As per Monday, January 25, the company rating was downgraded by BMO Capital Markets. The company was maintained on Monday, July 10 by Cowen & Co. The firm has “Outperform” rating by Credit Suisse given on Monday, May 9. On Tuesday, March 15 the stock rating was maintained by Jefferies with “Hold”. The stock of Bristol-Myers Squibb Co (NYSE:BMY) has “Outperform” rating given on Wednesday, April 26 by Robert W. Baird. The rating was maintained by Jefferies with “Hold” on Tuesday, June 14. Jefferies maintained it with “Hold” rating and $59 target in Thursday, August 27 report. The firm earned “Buy” rating on Tuesday, September 20 by Citigroup.

Investors sentiment decreased to 0.97 in Q4 2016. Its down 0.16, from 1.13 in 2016Q3. It turned negative, as 86 investors sold BMY shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. 1.14 billion shares or 1.92% more from 1.12 billion shares in 2016Q3 were reported. Evercore Wealth Management Lc holds 0.27% or 111,727 shares in its portfolio. Whittier Trust Com Of Nevada Incorporated, Nevada-based fund reported 122,652 shares. American Management Inc has 0.03% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 7,400 shares. Geode Cap Lc has invested 0.43% in Bristol-Myers Squibb Co (NYSE:BMY). Moreover, Neville Rodie Shaw has 0.7% invested in Bristol-Myers Squibb Co (NYSE:BMY). Bremer Tru National Association reported 19,259 shares. Choate Investment stated it has 0% in Bristol-Myers Squibb Co (NYSE:BMY). 3.34M were accumulated by Massachusetts Communications Ma. Invsts Asset Mngmt Of Georgia Ga Adv holds 0.19% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 4,478 shares. Boston Research & accumulated 0.27% or 8,130 shares. Natixis Asset Mgmt invested in 0.09% or 16,491 shares. American Management Company accumulated 2,090 shares or 0.04% of the stock. Interocean Capital Lc, a Illinois-based fund reported 11,028 shares. 16,992 are held by Donaldson Mngmt Llc. The New York-based Nottingham has invested 0.05% in Bristol-Myers Squibb Co (NYSE:BMY).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.